https://prabadinews.com/
  • October 9, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

IMS 2025: Quadruplet Regimens Enhance Depth of Response in Multiple Myeloma

An expert discusses the benefits of anti-CD38 quadruplet regimens for elderly multiple myeloma patients.

administrator

Related Articles